Table 5. Characteristics of the groups of interferon-α-induced depression with and without remission.
| Variable |
IFN-α-induced depression |
|
|---|---|---|
| With remission (N=156) | Without remission (N=126) | |
| Age (years) | ||
| <50 | 49 (31.4) | 40 (31.8) |
| 50–59 | 69 (44.2) | 42 (33.3) |
| ⩾60 | 38 (24.4) | 44 (34.9) |
| Sex | ||
| Female | 81 (51.9) | 77 (61.1) |
| Male | 75 (48.1) | 49 (38.9) |
| Urbanization | ||
| Low | 13 (8.3) | 15 (12.4) |
| Moderate | 24 (15.4) | 25 (20.7) |
| High | 78 (50.0) | 56 (46.3) |
| Very high | 41 (26.3) | 25 (20.7) |
| Income (NTD) | ||
| 0 | 16 (10.2) | 12 (9.5) |
| 1–15 840 | 24 (15.4) | 24 (19.1) |
| 15 841–25 000 | 87 (55.8) | 68 (54.0) |
| >25 000 | 29 (18.6) | 22 (17.4) |
| Medical diseases | ||
| Diabetes | 30 (19.2) | 19 (15.1) |
| Hypertension | 45 (28.9) | 44 (34.9) |
| Hypercholesterolemia | 39 (25.0) | 20 (15.9) |
| COPD | 30 (19.2) | 24 (19.1) |
| Heart failure | 2 (1.3) | 5 (4.0) |
| Coronary heart disease | 21 (13.5) | 19 (15.1) |
| Chronic kidney disease | 2 (1.3) | 1 (0.8) |
| Liver cirrhosis | 21 (13.5) | 16 (12.7) |
| Anemia | 12 (7.7) | 12 (9.5) |
| Thyroid disease | 8 (5.1) | 8 (6.4) |
| Anxiety disorder | 40 (25.6) | 49 (38.9) |
| Zolpidem use | 79 (50.6) | 71 (56.4) |
Abbreviations: COPD, chronic obstructive pulmonary disease; INF, interferon; NTD, New Taiwan dollar.